Exposure-based Cognitive Behavior Therapy vs Traditional Cognitive Behavior Therapy for Fibromyalgia
NCT ID: NCT05058911
Last Updated: 2023-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
274 participants
INTERVENTIONAL
2021-09-22
2023-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Objective Measurement of Pain Regulation in Individuals Who Have Received Internet-delivered Exposure-based Cognitive Behavior Therapy
NCT07054333
Pilot Study of Internet-based Cognitive Behavior Therapy for Fibromyalgia
NCT01468961
Internet-based Exposure-based Therapy for Fibromyalgia: A Randomized Controlled Trial.
NCT02638636
Cognitive Behavioral Therapy Trial in Fibromyalgia
NCT01004458
Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia
NCT00321451
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants in Exp-CBT and T-CBT are encouraged to work with self-help texts and complete regular homework exercises via a secure treatment platform. Both treatments are 10 weeks long, equally exhaustive, and involve approximately the same level of therapist support.
Primary outcome is the relative effect of Exp-CBT and T-CBT on FM severity as modelled using linear mixed models fitted on weekly Fibromyalgia Impact Questionnaire sum scores over the treatment period, testing the hypothesis of Exp-CBT superiority based on the coefficient for the time × group interaction. The investigators will also calculate the number of treatment completers in each treatment condition, defined as having commenced module five out of eight treatment modules. Detailed information regarding analysis of clinical efficacy is provided in the supplementary file.
In addition to clinical efficacy, the investigators will also investigate cost-effectiveness and mediational processes. The primary hypothesis is that Exp-CBT is significantly more efficacious than T-CBT in reducing FM severity, i.e., the Fibromyalgia Impact Questionnaire (FIQ) composite score indicative of symptoms and functional status, from the baseline assessment to the 10-week assessment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Internet-delivered exposure-based cognitive behavior therapy (Exp-CBT)
10-week self-help treatment delivered via a secure online platform, with regular therapist support.
Internet-delivered exposure-based cognitive behavior therapy
The primary treatment component is exposure to stimuli (situations and activities) that give rise to pain, distress, and unwanted emotional responses. The treatment proceeds in accordance with functional analysis. Exercises are tailored for the patient so that, for example, individuals whose main coping strategy is to be overly active (i.e., persistence behavior) are encouraged to sit down and observe pain and other aversive bodily sensations as they arise. The protocol also includes regular exercises where the participant is encouraged to observe and name physical sensations without acting on them.
Internet-delivered traditional cognitive behavior therapy (T-CBT)
10-week self-help treatment delivered via a secure online platform, with regular therapist support.
Internet-delivered traditional cognitive behavior therapy
This treatment is based on components typical of T-CBT for FM, such as relaxation, activity planning or pacing, cognitive restructuring techniques and stress management strategies.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Internet-delivered exposure-based cognitive behavior therapy
The primary treatment component is exposure to stimuli (situations and activities) that give rise to pain, distress, and unwanted emotional responses. The treatment proceeds in accordance with functional analysis. Exercises are tailored for the patient so that, for example, individuals whose main coping strategy is to be overly active (i.e., persistence behavior) are encouraged to sit down and observe pain and other aversive bodily sensations as they arise. The protocol also includes regular exercises where the participant is encouraged to observe and name physical sensations without acting on them.
Internet-delivered traditional cognitive behavior therapy
This treatment is based on components typical of T-CBT for FM, such as relaxation, activity planning or pacing, cognitive restructuring techniques and stress management strategies.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Access to the internet
* Completed pre-treatment assessment
* If on psychotropic medication, dose kept stable for at least 4 weeks before randomization and the participant agrees to keep it constant during treatment
Exclusion Criteria
* Suicidal ideation (≥ 4 on the suicide item of the MADRS-S at screening),
* Psychosis
* Alcohol or substance use disorder as primary diagnosis or likely to severely interfere with treatment
* Ongoing psychological treatment
* Pregnancy (\>29 wk gestation)
* Another somatic condition that requires immediate treatment and/or is deemed to be the primary condition
* Insufficient knowledge of the Swedish language or insufficient computer skills to benefit from the text-based online treatment.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uppsala University
OTHER
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maria Hedman-Lagerlöf
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Hedman-Lagerlöf, PhD
Role: PRINCIPAL_INVESTIGATOR
Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska Institutet
Solna, , Sweden
Uppsala University
Uppsala, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hedman-Lagerlof M, Gasslander N, Ahnlund Hoffmann A, Bragesjo M, Etzell A, Ezra S, Frostell E, Hedman-Lagerlof E, Ivert C, Liliequist B, Ljotsson B, Hoppe JM, Palmgren J, Spansk E, Sundstrom F, Sarnholm J, Tzavara G, Buhrman M, Axelsson E. Effect of exposure-based vs traditional cognitive behavior therapy for fibromyalgia: a two-site single-blind randomized controlled trial. Pain. 2024 Jun 1;165(6):1278-1288. doi: 10.1097/j.pain.0000000000003128. Epub 2023 Dec 15.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan: Study protocol including rudimentary data analysis plan
Document Type: Statistical Analysis Plan: Detailed information on data analysis
Document Type: Statistical Analysis Plan: Statistical Analysis Plan for mediation analysis
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-03302
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.